Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.5400
0.00 (0.00%)
At close: Oct 5, 2026
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 15.89 million as of October 9, 2026. It is the 41,074th most valuable company in the world and the 1,181st biggest in Australia. Its market cap has increased by 36.36% in one year.
Market Cap
15.89M
Enterprise Value
14.93M
Revenue
1.23M
Global Rank
Country Rank
#1,181 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2024, Cambium Bio's market cap has increased from 7.97M to 15.89M, an increase of 99.48%. That is a compound annual growth rate of 31.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 15.89M | 47.23% |
| Dec 31, 2025 | 10.80M | 103.21% |
| Dec 31, 2024 | 5.31M | -33.33% |
| Apr 5, 2024 | 7.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 21.69M |
| Imugene | 20.08M |
| Proteomics International Laboratories | 19.84M |
| Noxopharm | 19.05M |
| Algorae Pharmaceuticals | 18.25M |
| Ceryvyn Therapeutics | 17.78M |
| Patrys | 17.47M |
| Argenica Therapeutics | 16.70M |